Last reviewed · How we verify
NCT07055867
Epidemiological and Clinical Characteristics of Mpox Outbreak in Equateur, the DR Congo (Part1)
trial in Mpox (Monkeypox) in 122 participants. Enrolling by invitation.
31 December 2025
Quick facts
| Lead sponsor | Osaka Metropolitan University |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 122 |
| Start date | 1 August 2024 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Democratic Republic of the Congo |
Conditions studied
- Mpox (Monkeypox) — all drugs for Mpox (Monkeypox) →
Sponsor
Osaka Metropolitan University
Who can join
Eligibility, any sex, with Mpox (Monkeypox). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to characterize the clinical features of the 2024 mpox outbreak in Equateur Province of DRC and to identify associated risk factors. The main question it aims to answer is: * What are the clinical features of the 2024 mpox outbreak in Equateur Province of DRC? * What are the associated risk factors of the 2024 mpox outbreak? Participants which has mpox like symptoms will answer mpox investigations related questions and be collected skin lesions and whole blood samples.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07055867
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mpox (Monkeypox)
Currently open trials in the same condition.
- NCT07267390 — Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in Contacts · recruiting
- NCT06839989 — An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa · Phase 2 · recruiting
- NCT06353737 — Looking for Asymptomatic Mpox in a Population at High Risk · recruiting
Other Osaka Metropolitan University trials
Trials by the same sponsor.
- NCT06984705 — Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of C · enrolling by invitation
- NCT06694012 — Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2 · recruiting
- NCT07067723 — Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of C · enrolling by invitation
- NCT06432543 — Polyethylene Wear Particle Analysis of THA · recruiting
- NCT06426641 — Polyethylene Wear Particle Analysis of TKA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07055867 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Osaka Metropolitan University
- Last refreshed: 9 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07055867.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing